Pharmaceutial Intermediates
  • Ethyl 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate

    • Product Name   :   

      Ethyl 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate

    • CAS No   :   

      161798-01-2

    • Project State   :   

      Commercial

    General Description

    Factory Sells Best Quality Ethyl 2-(3-Formyl-4-hydroxyphenyl)-4-methylthiazole-5-carboxylate 161798-01-2 with USP

    • Molecular Formula:C14H13NO4S
    • Molecular Weight:291.328
    • Melting Point:116 °C 
    • Refractive Index:1.625 
    • Boiling Point:446.7 °C at 760 mmHg 
    • PKA:6.81±0.20(Predicted) 
    • Flash Point:223.9 °C 
    • PSA:104.73000 
    • Density:1.335 g/cm3 
    • LogP:2.81330 

    ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl thiazole-5-carboxylate(Cas 161798-01-2) Usage

    InChI:InChI=1/C14H13NO4S/c1-3-19-14(18)12-8(2)15-13(20-12)9-4-5-11(17)10(6-9)7-16/h4-7,17H,3H2,1-2H3

    161798-01-2 Relevant articles

    Design, synthesis, cytotoxic evaluation and molecular docking studies of novel thiazolyl α-aminophosphonates

    Gundluru, Mohan,Badavath, Vishnu Nayak,Shaik, Haroon Yasmin,Sudileti, Murali,Nemallapudi, Bakthavatchala Reddy,Gundala, Sravya,Zyryanov, Grigory V.,Cirandur, Suresh Reddy

    , p. 1139 - 1160 (2020/11/16)

    Abstract: A new class of thiazolyl α-ami...

    Method for synthesizing febuxostat and intermediate thereof

    -

    Paragraph 0109-0184, (2020/05/02)

    The invention relates to a method for sy...

    Febuxostat and intermediates and synthesis thereof

    -

    Paragraph 0081-0156, (2020/05/09)

    The invention relates to febuxostat and ...

    Synthesis, molecular docking, DFT study of novel N-benzyl-2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxamide derivatives and their antibacterial activity

    Sam Daniel Prabu,Lakshmanan, Sivalingam,Thirumurugan,Ramalakshmi,Arul Antony

    , p. 619 - 626 (2020/02/06)

    A series of febuxostat based new chemica...

    161798-01-2 Process route

    (2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester)
    161797-99-5

    (2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester)

    hexamethylenetetramine
    100-97-0

    hexamethylenetetramine

    ethyl 2‐(3‐formyl‐4‐hydroxyphenyl)‐4‐methylthiazole‐5‐carboxylate
    161798-01-2

    ethyl 2‐(3‐formyl‐4‐hydroxyphenyl)‐4‐methylthiazole‐5‐carboxylate

    Conditions
    Conditions Yield
    With methanesulfonic acid; boric acid; In cyclohexane; at 75 - 100 ℃; for 7h; Temperature; Reagent/catalyst; Solvent;
    91.2%
    (2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester); With methanesulfonic acid; boric acid; In cyclohexane; at 80 ℃;
    hexamethylenetetramine; In cyclohexane; at 75 ℃; for 7h; Temperature;
    91.2%
    With water; acetic acid; trifluoroacetic acid; at 100 ℃; for 2.5h;
    90%
    (2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester); hexamethylenetetramine; at 40 - 93 ℃; for 3h; Large scale;
    With acetic acid; In water; for 0.333333h; Temperature; Reagent/catalyst; Cooling with ice; Large scale;
    81.3%
    With methanesulfonic acid; at 75 ℃; for 10h;
    72.3%
    With trifluoroacetic acid; for 40h; Reflux;
    (2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester); hexamethylenetetramine; With trifluoroacetic acid; at 80 ℃; for 24h;
    With water; In toluene; for 0.166667h;
    With phosphorus pentoxide;
    (2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester); hexamethylenetetramine; at 75 ℃;
    With acetic acid; In water; at 20 ℃;
    With sulfuric acid; at 60 - 120 ℃;
    (2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester)
    161797-99-5

    (2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester)

    N,N-dimethyl-formamide
    68-12-2,33513-42-7

    N,N-dimethyl-formamide

    ethyl 2‐(3‐formyl‐4‐hydroxyphenyl)‐4‐methylthiazole‐5‐carboxylate
    161798-01-2

    ethyl 2‐(3‐formyl‐4‐hydroxyphenyl)‐4‐methylthiazole‐5‐carboxylate

    Conditions
    Conditions Yield
    (2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester); With n-butyllithium; In tetrahydrofuran; hexane; at -10 ℃; for 0.2h; Inert atmosphere;
    N,N-dimethyl-formamide; In tetrahydrofuran; hexane; at -10 ℃; for 0.5h; Inert atmosphere;
    With acetic acid; In tetrahydrofuran; hexane; at 10 ℃; for 0.166667h; Time; Inert atmosphere;
    96.6%

    161798-01-2 Upstream products

    • 609-15-4
      609-15-4

      ethyl 2-chloro-3-oxo-butyrate

    • 161797-99-5
      161797-99-5

      (2-(4-hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester)

    • 100-97-0
      100-97-0

      hexamethylenetetramine

    • 25984-63-8
      25984-63-8

      4-hydroxythiobenzamide

    161798-01-2 Downstream products

    • 161798-03-4
      161798-03-4

      2-(3-formyl-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

    • 1271738-74-9
      1271738-74-9

      ethyl 2-[3-((hydroxyimino)methyl)-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylate

    • 144060-53-7
      144060-53-7

      febuxostat

    • 160844-75-7
      160844-75-7

      2-(3-cyano-4-isobutyloxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester

    Top